Skip to main content

Seqirus Meets New Milestone in Pandemic Preparedness

Seqirus, the Holly Springs vaccine manufacturer, recently achieved another major milestone in its efforts to support the U.S. government’s pandemic preparedness efforts, showing it can now produce 150 million doses of a mammalian cell-derived flu vaccine in the first six months of pandemic declaration.

Pfizer Boosts North Carolina Footprint with $100 Million Expansion

Pfizer, the global pharmaceutical giant, will expand its vaccine-manufacturing plant in Sanford with a $100 million investment in gene therapy that will add 40 jobs to its workforce.

Lifestar Pharma Enters NC with Purchase of Durham Facility

Citing the Research Triangle region’s prevalence of top talent and nationally ranked research universities, New Jersey-based Lifestar Pharma has purchased a Durham building for a new R&D and manufacturing operation.

Alcami, UNCW Partner for Student Workplace Experience

A public/private partnership is providing biology and chemistry majors at the University of North Carolina Wilmington with unique insight into the pharmaceutical services industry.

World-Leading Seqirus Flu Vax Factory in NC Makes History -- Again

The billion-dollar cell culture Seqirus vaccine factory in Holly Springs has hit yet another milestone. The highly skilled workers at the sprawling factory southeast of Raleigh successfully produced the world’s first cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.

CiVentiChem Gets First FDA Nod on Commercial API from Cary HQ

CiVentiChem has received its first U.S. Food and Drug Administration approval for a generic commercial active pharmaceutical ingredient (API) manufactured at its Cary headquarters.

Grifols’ Zika Test Available for Blood Screening in Europe

A test for screening blood donations for presence of the Zika virus is now being sold in Europe by Grifols, a global developer of plasma-derived medicines that has 2,500 employees in North Carolina.

Patheon Agrees to $5.2 Billion Acquisition by Thermo Fisher Scientific

Durham-based Patheon N.V., a global provider of pharmaceutical development and manufacturing services that has a large production facility in Greenville, will be acquired by Thermo Fisher Scientific in a deal worth about $5.2 billion.

Glenmark Hiring at Monroe Pharma Manufacturing Site

Glenmark Pharmaceuticals, an India-based global pharmaceutical company, is hiring at its pharmaceutical manufacturing facility in the Union County community of Monroe, outside Charlotte.

Newly Approved Drug for Duchenne Muscular Dystrophy Made in NC

A new treatment for Duchenne muscular dystrophy has been approved by the U.S. Food and Drug Administration and will be manufactured in Wilmington, N.C.

Pages

Subscribe to RSS - Biomanufacturing